Amikacin pharmacokinetics in elderly patients with severe infections-Reference-Cited by-同舟云学术

Amikacin pharmacokinetics in elderly patients with severe infections

Published:2022-08 Issue: Volume:175 Page:106219
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Medellín-Garibay Susanna E.,Romano-Aguilar Melissa^ORCID,Parada Alejandro,Suárez David,Romano-Moreno Silvia,Barcia Emilia^ORCID,Cervero Miguel^ORCID,García Benito

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference48 articles.

1. Aronoff D. Amikacin;Nesbitt,2017

2. Aminoglycosides use in patients over 75 years old;Fraisse;Age Ageing,2014

3. Amikacin initial dose in critically ill patients: a nonparametric approach to optimize a priori pharmacokinetic/pharmacodynamic target attainments in individual patients;Boidin;Antimicrob. Agents Chemother.,2019

4. Optimizing the initial amikacin dosage in adults;White;Antimicrob. Agents Chemother.,2015

5. Evaluation of current amikacin dosing recommendations and development of an interactive nomogram: the role of albumin;Perez-Blanco;Pharmaceutics,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-informed drug development in pediatric, pregnancy and geriatric drug development: States of the art and future;Advanced Drug Delivery Reviews;2024-08

2. Population pharmacokinetics of antibacterial agents in the older population: a literature review;Expert Review of Clinical Pharmacology;2024-01-02

3. Pharmacokinetics of Antibacterial Agents in the Elderly: The Body of Evidence;Biomedicines;2023-06-04

4. Therapeutic Drug Monitoring of Amikacin in Neutropenic Oncology Patients;Antibiotics;2023-02-11